导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.47% | 388/668 |
| 近一周 | 0.02% | 158/774 |
| 近一月 | -0.07% | 180/766 |
| 近一季 | 0.48% | 146/751 |
| 近半年 | 0.45% | 459/717 |
| 近一年 | 1.64% | 380/666 |
| 近两年 | 5.29% | 451/560 |
| 近三年 | 9.13% | 380/511 |
| 成立以来 | 37.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.04% 446/755 |
1.05% 381/838 |
-0.19% 596/871 |
- - |
| 2024 | 3.32% 559/819 |
1.10% 1804/3226 |
0.75% 380/502 |
0.05% 551/800 |
1.38% 590/819 |
| 2023 | 3.64% 1204/3108 |
0.78% 1436/2776 |
1.40% 593/2849 |
0.43% 1734/2940 |
0.97% 1079/3108 |
| 2022 | 2.81% 514/2726 |
0.63% 574/1949 |
1.10% 708/2522 |
1.38% 406/2598 |
-0.32% 1483/2732 |
| 2021 | 4.48% 721/2409 |
0.85% 614/2068 |
1.15% 748/2668 |
1.30% 830/2731 |
1.10% 1088/2416 |
| 2020 | 2.93% 687/2196 |
2.53% 299/1576 |
-0.15% 846/2274 |
-0.60% 1936/2475 |
1.15% 671/2563 |
| 2019 | 3.84% 797/1720 |
1.40% 718/1682 |
0.52% 937/1825 |
0.82% 1382/1762 |
1.05% 805/1956 |
| 2018 | 6.24% 544/1267 |
- - |
1.51% 241/1345 |
1.49% 592/1404 |
1.42% 699/1542 |
| 2017 | 3.88% 32/1017 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 创金合信尊丰纯债A VS. () |